Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Israel
/
Corporate bonds
/
TEVA5295245
/
Analysis
T
T
T
Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029
TEVA5295245
FINRA
TEVA5295245
FINRA
TEVA5295245
FINRA
TEVA5295245
FINRA
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
TEVA5295245 analysis
Overview
Coupon
Redemption
Risks
More
Key facts
Issuer
Teva Pharmaceutical Finance Netherlands III BV
Issue date
Nov 9, 2021
Maturity date
May 9, 2029
Outstanding amount
1.00 B
USD
Face value
1,000.00
USD
Minimum denomination
200,000.00
USD
Coupon
5.13% (Variable)
Yield to maturity
5.74%
Acts as a financing subsidiary/Special purpose entity
Show more
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.
Start trial